Ryan Saadi is the founder of Tevogen Bio. Tevogen Bio has raised $50M in total funding. Latest round: Growth.
Dr. Ryan Saadi is the founding CEO of Tevogen Bio, a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics. He has been recognized with the Boy Scouts of America Distinguished Citizen Award and for promoting a business model focused on patient affordability.
Full founder directory · Investor directory · Company funding database · Fundraising library